Conclusions Trop-2 protein overexpression is significantly associated with higher tumor grade and serves as an independent prognostic factor for DFS in endometrioid endometrial cancer.

For patients with advanced or recurrent endometrial cancer ... effects of any grade. Notably, grade 3 (severe) to 4 (life-threatening) treatment-related side effects occurring in 76% and 66% of ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

This trial included 36 women with ovarian cancer and six with endometrial cancer ... fatigue and vomiting were primarily grade 1/2 [7] Naumann et al. (2009) No grade 4 toxicities were elicited ...

GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus ...

(2) These cells are activated ... patients with MSLN-expressing solid tumors, including mesothelioma and ovarian cancer, demonstrated encouraging antitumor responses. However, dose-limiting toxicities ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

Interim data was announced last November, where 6 out of 11 patients with platinum-resistant ovarian cancer had tumor shrinkage with ... can be amplified. High-grade thrombocytopenia (reduction ...